RxDoctor Payments Data

Natalie Strand, MD

Pain Medicine · Scottsdale, AZNPI 1538137823

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 36.5% of the total. Reporting peaked in 2021 at $9,290 and has fallen 66.3% since, to $3,131 in 2025.

$21,589in general payments, 2019–2025

Across 83 payments — averaging $260.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Nevro Corp.$7K
  • Tonix Medicines, Inc.$3K
  • Stratus Medical, LLC$2K
  • Saluda Medical Americas, Inc.$783
  • Medtronic$652
  • plus $432 from 7 others

What the payments were for

  • Consulting fees$10,01346%
  • Speaking & faculty fees$7,93837%
  • Travel & lodging$170%
  • Food & beverage$3,62217%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,589 in reported general payments places this provider in the 85th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$43,154
Medicare patients
198
Services billed
483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin20$754
Pregabalin14$485
Nortriptyline Hcl14$129

Paid to pharmacies, not to this prescriber.

Other pain medicine in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →